Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Nkarta, Inc. | 146 735 | déclaré | 15 janv. 2025 | tx 18+756 600−20 065 |
| OncoMed Pharmaceuticals Inc | 0 | déclaré | 23 avr. 2019 | tx 44+393 552−95 672 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 15 janv. 2025 | SALE | Nkarta, Inc. | 9 584 | 2.20 USD | |
| 03 janv. 2025 | GRANT_AWARD | Nkarta, Inc. | 52 500 | 0.00 USD | |
| 03 janv. 2025 | GRANT_AWARD | Nkarta, Inc. | 105 000 | 0.00 USD | deriv |
| 16 juil. 2024 | SALE | Nkarta, Inc. | 3 396 | 8.00 USD | |
| 18 juin 2024 | SALE | Nkarta, Inc. | 727 | 5.60 USD | |
| 16 janv. 2024 | SALE | Nkarta, Inc. | 4 554 | 8.74 USD | |
| 04 janv. 2024 | GRANT_AWARD | Nkarta, Inc. | 56 000 | 0.00 USD | |
| 04 janv. 2024 | GRANT_AWARD | Nkarta, Inc. | 112 500 | 0.00 USD | deriv |
| 20 juin 2023 | SALE | Nkarta, Inc. | 701 | 4.85 USD | |
| 17 janv. 2023 | SALE | Nkarta, Inc. | 1 103 | 5.49 USD | |
| 13 janv. 2023 | GRANT_AWARD | Nkarta, Inc. | 37 500 | 0.00 USD | |
| 13 janv. 2023 | GRANT_AWARD | Nkarta, Inc. | 75 000 | 0.00 USD | deriv |
| 17 juin 2022 | GRANT_AWARD | Nkarta, Inc. | 8 000 | 0.00 USD | |
| 17 juin 2022 | GRANT_AWARD | Nkarta, Inc. | 50 500 | 0.00 USD | deriv |
| 14 janv. 2022 | GRANT_AWARD | Nkarta, Inc. | 12 800 | 0.00 USD | |
| 14 janv. 2022 | GRANT_AWARD | Nkarta, Inc. | 76 800 | 0.00 USD | deriv |
| 14 janv. 2022 | GRANT_AWARD | Nkarta, Inc. | 20 000 | 0.00 USD | deriv |
| 26 oct. 2020 | GRANT_AWARD | Nkarta, Inc. | 150 000 | 0.00 USD | deriv |
| 23 avr. 2019 | TENDER | OncoMed Pharmaceuticals Inc | 39 488 | — | |
| 10 oct. 2018 | SALE | OncoMed Pharmaceuticals Inc | 1 156 | 2.02 USD | |
| 09 oct. 2018 | SALE | OncoMed Pharmaceuticals Inc | 1 686 | 2.13 USD | |
| 24 avr. 2018 | SALE | OncoMed Pharmaceuticals Inc | 4 051 | 2.68 USD | |
| 04 janv. 2018 | GRANT_AWARD | OncoMed Pharmaceuticals Inc | 70 000 | 0.00 USD | deriv |
| 10 oct. 2017 | SALE | OncoMed Pharmaceuticals Inc | 1 202 | 4.24 USD | |
| 10 oct. 2017 | SALE | OncoMed Pharmaceuticals Inc | 46 | 4.26 USD | anomalie |